CureVac
Last updated: October 09, 2024
Ingmar Hoerr, CEO
Germany | Funding: $2.1B (+)
Website: http://www.curevac.com/
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
Website: http://www.curevac.com/
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.